400 is a magic number for Dendreon investors. It's the level of annualized Provenge sales, in millions, that the company projects will allow them to achieve profitability. However, with today's preliminary fourth-quarter results showing only mid-single-digit growth, progress toward that goal is painstakingly slow. In the following video, Brenton discusses the release in more detail.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Dendreon Offers a Sneak Peek
Dendreon releases preliminary quarterly results.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Dendreon Corp and Johnson & Johnson. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned


*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.